How to master raw material ID testing

Now, more than ever, the assurance that therapeutic and preventative drugs have gone through rigorous and regulated quality control is a primary driver of patient trust in personalized medicines and vaccines. 

The nature of the pharmaceutical industry is transforming to focus more on biologic drug products and parenteral treatments manufactured in cGMP environments, which is vastly different from traditional oral tablets or capsules.

Despite these industry changes, the identification of APIs, excipients, and cell culture media for drug manufacturing and the identification of drug substances remains a constant need, not to mention the importance of brand protection against counterfeits.

In this on-demand webinar, Thermo Fisher Scientific explores the evolving role of handheld and portable instruments to drive quality improvements and manufacturing success.

Key learning outcomes

• Understand why chemically defined cell culture media are trending and how to differentiate between similar media
• Examine new opportunities to test ionic salts and close the gap toward 100 percent raw material identification
• Explore time and productivity savings observed by performing quantitative analysis using handheld spectroscopy
• See how real-time release testing can be accomplished and achieve drug substance and drug product identification